New biotech startup GentiBio lands $20M, inks licensing deals with Seattle Children’s and BRI
Boston-based biotech startup GentiBio has secured licensing deals with Seattle Children’s Research Institute and Benaroya Research Institute at Virginia Mason. The technology from both Seattle-based institutions will assist with the company’s goal of treating autoimmune, alloimmune, autoinflammatory, and allergic diseases.